Harrow To Report Second Quarter 2026 Financial Results After Market Close on August 10, 2026Unusual Whales·Jul 27 at 06:02 AMHROW+0.67%HROWM0.00%
Harrow updates financial calendar with upcoming quarterly results release and investor callPUBT·Jul 27 at 06:02 AMHROWL0.00%HROW+0.67%
Can New Retina Data Deepen Harrow’s (HROW) Moat In Ophthalmology Or Just Refine Its Story?Simplywall·Jul 20 at 08:08 PMHROW+0.67%HROWM0.00%
Harrow says QUELL trial of IHEEZO posts topline data in Q4 2026PUBT·Jul 20 at 06:07 AMHROW+0.67%HROWM0.00%
How Investors May Respond To Harrow (HROW) Taking Over BYOOVIZ US Commercialization And Ophthalmic BiosimilarsSimplywall·Jul 10 at 03:03 AMHROW+0.67%HROWM0.00%
Harrow (NASDAQ:HROW) Trading Down 4.8% - What's Next?Market Beat·Jul 9 at 01:40 PMHROW+0.67%HROWM0.00%
Harrow (HROW) Could Be 38% Undervalued Following BYOOVIZ LaunchSimplywall·Jul 3 at 10:57 AMHROWM0.00%HROW+0.67%
Analyst Reaffirms Buy on Harrow Health, Citing Expanding Ophthalmic Franchise and Long-Term Growth PipelineTip Ranks·Jul 1 at 08:45 AMHROWM0.00%HROWL0.00%
Harrow holds annual shareholder meeting, elects four directorsPUBT·Jun 22 at 06:31 AMHROW+0.67%HROWL0.00%
Harrow Adds Another Piece To Ophthalmology Strategybenzinga_article·Jun 11 at 10:42 AMHROW+0.67%HROWL0.00%
Transcript: Harrow Q1 2026 Earnings Conference Callbenzinga_article·May 12 at 10:29 AMHROW+0.67%HROWL0.00%
Harrow shares are trading lower after the company reported worse-than-expected Q1 financial results.benzinga_article·May 11 at 03:27 PMHROWL0.00%HROWM0.00%
April 2026's Top Growth Companies With Strong Insider OwnershipSimplywall·Apr 13 at 01:02 PMUXIN+0.72%ETON+1.87%
